Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Rochester
With
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Aim 2: Deploy theorized implementation strategies using a type-2 hybrid stepped-wedge randomized cluster trial The department of family medicine will roll out the clinical intervention (TBHBPM).
To improve rigor in evaluation, the study biostatistician will use computer-generated numbers to randomly assign each of the eight suites to when they will begin the intervention during one of three wedges (Figure 1). The study team and investigators will randomize two suites in the first wedge and three each to the second and third wedge.
Aim 3: Assess the impact of implementation strategies using specific metrics based on RE-AIM
Aim 4: Test theoretical assumptions underlying the implementation strategies
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
ELIGIBILITY CRITERIA
Clinicians and Staff Eligibility Criteria Practice employees (practice leaders, administrators, clinicians, or staff) that work with hypertensive patients during the study period (scheduling appointments, coordinating care, measuring blood pressure, responding to questions, and/or treating their blood pressure)
Current HFM patient 18-85 years of age with hypertension diagnosis
Diagnosis of hypertension based on ICD-10 codes of I10-I14
at least one HFM health visit and hypertension diagnosis beginning no later than 7/1/2021.
You may not be if
Not current patient in the participating practices
Diagnosis of dementia, end-stage renal disease, and/or in hospice
Currently pregnant
Clareo Health | Team-Based Home Blood Pressure Monitoring
